Autopsy report · NCT02838030

Efficacy of Aspirin and L-arginine in High Risk Preeclamptic

“COVID-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 1 month before it started.
• Suspended: paused, and may or may not restart.
• 82 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 2

Sponsor

University of Guadalajara

Sponsor type

University, hospital or other

Conditions

High Risk Pregnancy

Interventions

L-arginine; Placebo (for L-arginine); acetylsalicylic acid

Participants

82 (planned, not actual)

Sites

1

Countries

Mexico

Trials that died the same way

• Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
  “COVID pandemic” (90% match in meaning)
• Dry Needling for Patients With Back Pain
  “COVID-19” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.